TGFB1 and neoplasm: Alternative immune checkpoint molecules, tumor-intrinsic interferon-γ signaling, and TGF-β-dependent exclusion of CD8+ CTLs have been proposed as resistance mechanisms in multiple tumors, but colorectal-specific resistance mechanisms remain to be elucidated [152–154].